BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20299818)

  • 1. Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison syndrome: an intra-individual comparison using different dosages in patients and controls.
    Kuiper P; Biemond I; Masclee AA; Jansen JB; Verspaget HW; Lamers CB
    Pancreatology; 2010; 10(1):14-8. PubMed ID: 20299818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
    Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment.
    Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA
    Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
    Jansen JB; Lamers CB
    Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome.
    Brady CE
    Am J Gastroenterol; 1991 Feb; 86(2):129-34. PubMed ID: 1992623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
    Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
    Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity, specificity and predictive values of the secretin infusion test in the diagnosis of gastrinoma.
    Poynard T; Mignon M; Accary JP; Bonfils S
    Gastroenterol Clin Biol; 1986; 10(6-7):492-6. PubMed ID: 3758593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum gastrin response to secretin after vagotomy.
    Feldman M; Walsh JH; Richardson CT
    Dig Dis Sci; 1980 Dec; 25(12):921-3. PubMed ID: 7449589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Zollinger-Ellison syndrome with basal gastrin and non-diagnostic stimulation tests (secretin and calcium)].
    Erdozain JC; Martín de Argila C; Moreira VF; Moreno A
    Med Clin (Barc); 1993 Jan; 100(1):37-8. PubMed ID: 8429704
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gastrinoma: diagnosis and management of Zollinger-Ellison syndrome].
    Sugihara K
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1044-8. PubMed ID: 6150432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
    Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
    Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
    Wada M; Komoto I; Doi R; Imamura M
    World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secretin stimulation and the gastrinemic response. Usefulness for diagnosis of Zollinger-Ellison syndrome].
    Sategna-Guidetti C; Imarisio P; de la Pierre M
    Recenti Prog Med; 1982 Jun; 72(6):744-52. PubMed ID: 6755583
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of gastrinoma by the secretin suppression test.
    Bradley EL; Galambos JT
    Surg Gynecol Obstet; 1976 Nov; 143(5):784-8. PubMed ID: 982259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.
    Lamers CG; Van Tongeren JH
    Gut; 1977 Feb; 18(2):128-35. PubMed ID: 323117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome.
    Metz DC; Buchanan M; Purich E; Fein S
    Aliment Pharmacol Ther; 2001 May; 15(5):669-76. PubMed ID: 11328261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.
    Rigaud D; Accary JP; Mignon M; Bonfils S
    Dig Dis Sci; 1984 Aug; 29(8):696-702. PubMed ID: 6745029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.
    Thom AK; Norton JA; Doppman JL; Miller DL; Chang R; Jensen RT
    Surgery; 1992 Dec; 112(6):1002-8; discussion 1008-9. PubMed ID: 1455303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
    Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome.
    Mignon M; Rigaud D; Cambray S; Chayvialle JA; Accary JP; René E; Vatier J; Bonfils S
    Scand J Gastroenterol; 1985 Sep; 20(7):791-7. PubMed ID: 4048832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.